| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Options Exercise | $0 | +56,205 | +15% | $0.000000 | 424,949 | 01 Feb 2022 | Direct | |
| transaction | LLY | Common Stock | Tax liability | $6,176,466 | -25,170 | -5.9% | $245.39 | 399,779 | 01 Feb 2022 | Direct | |
| holding | LLY | Common Stock | 63,500 | 01 Feb 2022 | By David A. Ricks SLAT | F1 | |||||
| holding | LLY | Common Stock | 7,090 | 01 Feb 2022 | 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Options Exercise | $0 | -56,205 | -100% | $0.000000* | 0 | 01 Feb 2022 | Common Stock | 56,205 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |